title: Leveraging the real value of laboratory medicine with the value proposition.
abstract: Improving quality and patient safety, containing costs and delivering value-for-money are the key drivers of change in the delivery of healthcare and have stimulated a shift from an activity-based service to a service based on patient-outcomes. The delivery of an outcomes-based healthcare agenda requires that the real value of laboratory medicine to all stakeholders be understood, effectively defined and communicated. The value proposition of any product or service is the link between the provider and the needs of the customer describing the utility of the product or service in terms of benefit to the customer. The framework of a value proposition for laboratory medicine provides the core business case that drives key activities in the evolution and maintenance of high quality healthcare from research through to adoption and quality improvement in an established service. The framework of a value proposition for laboratory medicine is described. The content is endorsed by IFCC and WASPaLM.
authors.affiliation: Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford OX2 6GG, United Kingdom.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Price
authors.affiliation: ARC Consulting, Mt Lawley, W, 6050, Australia.
authors.forename: Andrew St
authors.initials: AS
authors.lastname: John
authors.affiliation: Laboratories of Pathology, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Christenson
authors.affiliation: Clinical Laboratory, Catharina Hospital and Dept. of Biomedical Technology, Technical University Eindhoven, Eindhoven, The Netherlands.
authors.forename: Volker
authors.initials: V
authors.lastname: Scharnhorst
authors.affiliation: Department of Clinical Pharmacology, University Medicine Göttingen (UMG), Kreuzbergring 36, 37075 Göttingen, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Oellerich
authors.affiliation: Department of Pathology, University of Texas Southwestern Medical Center and Children's Medical Center, 1935 Medical District Drive, Dallas, TX 75235, USA.
authors.forename: Patricia
authors.initials: P
authors.lastname: Jones
authors.affiliation: School of Pharmacy and Medical Sciences, University of South Australia and Chemical Pathology Directorate, SA Pathology, Adelaide, South Australia 5000, Australia. Electronic address: howard.morris@sa.gov.au.
authors.forename: Howard A
authors.initials: HA
authors.lastname: Morris
mesh_terms: D003695:Delivery of Health Care / Q000191:economics; D006801:Humans; D013677:Medical Laboratory Science / Q000191:economics*; D061214:Patient Safety / Q000191:economics; D058996:Quality Improvement / Q000191:economics
keywords: Clinical effectiveness; Cost effectiveness; Evidence-based laboratory medicine; Healthcare quality; Healthcare safety; Value of laboratory medicine; Value proposition